Skip to content

Medical emergency? What to do

Roche says unsure why Japan warned against Tamiflu

3-RXPublished March 23, 20072 min read

Key points

  • Swiss drugmaker Roche Holding AG said on Thursday it was unsure why the Japanese government had warned that influenza drug Tamiflu should not be given to teenagers.
  • "Roche does not really understand the rationale for the actions taken by the Japanese government," Rupp said.
  • The ministry has said it would carry out a detailed investigation of the cases of abnormal behaviour.
  • "You've seen the new data, that's actually showing in the U.S. database that psychiatric symptoms are even lower in patients treated with Tamiflu compared to those who did not get drug," Rupp said.

Swiss drugmaker Roche Holding AG said on Thursday it was unsure why the Japanese government had warned that influenza drug Tamiflu should not be given to teenagers.

No definite link had been established between Tamiflu, seen as effective against a possible pandemic triggered by bird flu, and reports of young people injured by jumping from buildings after taking the drug, Roche spokeswoman Martina Rupp said.

"Roche does not really understand the rationale for the actions taken by the Japanese government," Rupp said. "There is no causal relationship established between Tamiflu and these reports."

Japan's Health Ministry has told importers of Tamiflu to warn doctors not to prescribe it to those aged 10 to 19.

The ministry has said it would carry out a detailed investigation of the cases of abnormal behaviour.

Roche has said new data from the United States and Japan showed there was no established causal link between Tamiflu and neuropsychiatric symptoms.

"You've seen the new data, that's actually showing in the U.S. database that psychiatric symptoms are even lower in patients treated with Tamiflu compared to those who did not get drug," Rupp said. "And I think that the scientific data that we have is quite strong and really shows that there is no established causality."

It is unclear whether the warning will affect sales of Tamiflu in Japan, Rupp said.

But the warning is unlikely to hit Roche's future earnings profile, said Helvea analyst Andrew Fellows, who has a buy rating on Roche stock.

"Tamiflu sales at Roche have received an enormous boost following the panic over bird flu, with sales of over 2 billion Swiss francs ($1.65 billion) generated in 2006 and likely in 2007, compared to a normalised annual rate of around 400 million Swiss francs," Fellows said in a note.

Pandemic sales will continue into 2008 but at a lower rate, Fellows said, and will gradually be replaced by higher margin cancer drugs, boosting Roche's gross margins.

"Tamiflu is irrelevant to our investment case," he said.

Roche shares were up 1.5 percent at 221.20 Swiss francs at 1408 GMT.

Roche's Rupp said the company was not planning any specific actions in response to the Japanese warning.

"There are 45 million people who took Tamiflu worldwide up to date (and the number affected) is really very small," she said.

"We do take this very seriously and we will continue to monitor this and to study this but you have to be aware that rare cases of neuropsychiatric events have also been reported in patients who were not taking Tamiflu."

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug NewsFlu

Keep reading

Drug News

Drug shows early promise in treating seizures

A study out today in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure. The discovery…

5 min read

Flu

Deadly new bird flu vindicates controversial research

Scientists in the Dutch city of Rotterdam know precisely what it takes for a bird flu to mutate into a potential human pandemic strain - because they've created just such mutant viruses in the laboratory. So as they…

4 min read

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.